Amir Bar-Ilan

Title: Amir Bar-Ilan: Innovator in Ocular Drug Delivery

Introduction

Amir Bar-Ilan is a notable inventor based in Neve Monsson, Israel. He has made significant contributions to the field of ocular drug delivery, focusing on innovative methods to enhance the bioavailability of medications administered to the eye. His work is particularly relevant in the treatment of various eye conditions, including glaucoma.

Latest Patents

Amir Bar-Ilan holds a patent for "Submicron emulsions as ocular drug delivery vehicles." This invention describes an ocular drug delivery vehicle composed of an oil-in-water submicron emulsion. The formulation includes approximately 0.5 to 50% of a first component of oil, 0.1 to 10% of a second component of an emulsifier, and 0.05 to 5% of a non-ionic surfactant, along with an aqueous component. The mean droplet size is in the submicron range, specifically below about 0.5 µm, and ideally between 0.1 and 0.3 µm. The patent also covers topical pharmaceutical compositions containing various drugs, such as anti-glaucoma medications, local anesthetics, steroids, and antibiotics, all designed to reduce irritation and improve drug delivery efficiency.

Career Highlights

Amir Bar-Ilan is associated with Pharmos Corporation, where he continues to develop innovative solutions in drug delivery systems. His work has been instrumental in advancing the field of ocular therapeutics, providing new avenues for effective treatment options.

Collaborations

Amir collaborates with notable colleagues, including Haim Aviv and Doron Friedman, who contribute to the research and development efforts at Pharmos Corporation.

Conclusion

Amir Bar-Ilan's contributions to ocular drug delivery through his innovative patent highlight his role as a key inventor in the field. His work not only enhances the effectiveness of treatments but also improves patient comfort and outcomes.